Neurogene(NGNE)
$22.15-0.78 (-3.40%)
NGNE
Neurogene financials statements
$22.15
At close:-0.78 (-3.40%)
Want to see NGNE full AI Analyst Report?
Neurogene (NGNE) Ratios
652 Followers
Neurogene Ratios
NGNE's free cash flow for Q3 2026 was $-29.46M. For the 2026 fiscal year, NGNE's free cash flow was decreased by $-315.00K and operating cash flow was $-29.14M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 16.56 | 20.84 | 8.72 | 12.74 | 6.81 |
| Quick Ratio | 16.56 | 20.84 | 8.72 | 12.74 | 6.64 |
| Cash Ratio | 6.33 | 9.01 | 6.45 | 12.33 | 6.50 |
| Solvency Ratio | -3.68 | -2.84 | -0.90 | -4.89 | -0.26 |
| Operating Cash Flow Ratio | -4.70 | -4.66 | -2.24 | -7.94 | -4.27 |
| Short-Term Operating Cash Flow Coverage | -25.19 | -23.54 | 0.00 | 0.00 | -38.00 |
| Net Current Asset Value | $ 248.05M | $ 290.57M | $ 163.80M | $ 74.08M | $ -119.40M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.04 | 0.07 | 0.04 | 0.06 |
| Debt-to-Equity Ratio | 0.04 | 0.04 | 0.09 | 0.05 | -0.07 |
| Debt-to-Capital Ratio | 0.04 | 0.04 | 0.08 | 0.05 | -0.08 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.09 | 1.08 | 1.20 | 1.11 | -1.10 |
| Debt Service Coverage Ratio | -28.43 | -23.87 | -4357.17 | -25995.50 | -40.61 |
| Interest Coverage Ratio | -20641.60 | -6883.75 | -4631.92 | -28258.50 | 0.00 |
| Debt to Market Cap | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.47 | 0.71 | 1.27 | 0.37 | 0.12 |
| Net Debt to EBITDA | 1.08 | 1.73 | 2.52 | 1.49 | 1.29 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | -251.03% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | -8122.38% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | -7771.35% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | -8930.27% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | -8123.68% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | -8123.68% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | -8123.68% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 87.54% | 90.97% | 65.34% | 97.65% | 99.97% |
| Return on Assets (ROA) | -31.31% | -22.38% | -16.32% | -50.51% | -49.78% |
| Return on Equity (ROE) | -34.11% | -24.21% | -19.52% | -55.96% | 54.98% |
| Return on Capital Employed (ROCE) | -37.92% | -25.77% | -27.85% | -55.08% | -55.76% |
| Return on Invested Capital (ROIC) | -37.50% | -25.53% | -27.45% | -54.70% | -54.65% |
| Return on Tangible Assets | -31.31% | -22.38% | -16.32% | -50.51% | -49.84% |
| Earnings Yield | -20.72% | -18.71% | -14.61% | -42.28% | -0.95% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 1.43 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.63 | 2.43 | 1.26 | 5.11 | 7.51 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 22.09 |
| Fixed Asset Turnover | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -223.32 | 105.52 | -290.48 | -71.38 | -32.10 |
| Days of Sales Outstanding | 0.00 | 255.70 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 16.52 |
| Days of Payables Outstanding | 223.32 | 150.18 | 290.48 | 71.38 | 48.62 |
| Operating Cycle | 0.00 | 255.70 | 0.00 | 0.00 | 16.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.65 | -4.02 | -4.01 | -4.12 | -0.84 |
| Free Cash Flow Per Share | -3.70 | -4.07 | -4.03 | -4.29 | -1.18 |
| Dividend Paid and CapEx Coverage Ratio | -65.23 | -87.38 | -160.19 | -23.69 | -2.53 |
| Capital Expenditure Coverage Ratio | -65.23 | -87.38 | -160.19 | -23.69 | -2.53 |
| Operating Cash Flow Coverage Ratio | -7.80 | -5.68 | -3.16 | -11.27 | -7.22 |
| Operating Cash Flow to Sales Ratio | 0.00 | -76.33 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -17.97% | -17.78% | -20.82% | -42.17% | -1.22% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.86 | -5.34 | -6.84 | -2.37 | -105.03 |
| Price-to-Sales (P/S) Ratio | 0.00 | 434.14 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.65 | 1.29 | 1.34 | 1.32 | -57.75 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.57 | -5.62 | -4.80 | -2.37 | -81.92 |
| Price-to-Operating Cash Flow Ratio | -5.65 | -5.69 | -4.83 | -2.47 | -114.35 |
| Price-to-Earnings Growth (PEG) Ratio | 5.20 | -0.10 | 0.20 | -0.01 | -2.40 |
| Enterprise Value Multiple | -3.92 | -3.86 | -2.23 | -1.02 | -105.71 |
| Enterprise Value | 342.12M | 277.43M | 116.57M | 53.21M | 5.24B |
| EV to EBITDA | -3.92 | -3.86 | -2.23 | -1.02 | -105.71 |
| EV to Sales | 0.00 | 299.92 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -4.37 | -3.88 | -2.25 | -0.97 | -80.93 |
| EV to Operating Cash Flow | -4.43 | -3.93 | -2.27 | -1.01 | -112.97 |
| Tangible Book Value Per Share | 12.51 | 17.67 | 14.51 | 7.69 | -1.67 |
| Shareholders’ Equity Per Share | 12.51 | 17.67 | 14.51 | 7.69 | -1.67 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -4.27 | -4.28 | -2.83 | -4.30 | -0.92 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.65 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 65.86 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 24.45 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 8.99 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.85 | 0.94 | 1.42 | 0.96 | 0.92 |
Currency in USD

